Nissan Chemical Files Livalo Patent Suit against Sawai in US

July 31, 2014
Nissan Chemical Industries has recently filed a patent infringement lawsuit in the US against Sawai Pharmaceutical and its US subsidiary, which filed its generic version of the hyperlipidemia treatment Livalo (pitavastatin) for FDA approval. This means that the approval could...read more